Patrick James Orme

Array ( [id] => 8490171 [patent_doc_number] => 20120289578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'USE OF RNA INTERFERENCE FOR TREATING OR REDUCING PAIN' [patent_app_type] => utility [patent_app_number] => 13/182707 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2091 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082046 [patent_doc_number] => 20130267576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => '(NUCLEIC ACID)-POLYSACCHARIDE COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/810533 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7594 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212104 [patent_doc_number] => 20140011281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'Direct Reprogramming of Cells to Cardiac Myocyte Fate' [patent_app_type] => utility [patent_app_number] => 13/808311 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8557 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777974 [patent_doc_number] => 08853178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => utility [patent_app_number] => 13/177462 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34143 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582254 [patent_doc_number] => 08772258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Single walled carbon nanotube/sirna complexes and methods related thereto' [patent_app_type] => utility [patent_app_number] => 13/175314 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 31 [patent_no_of_words] => 16280 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10837998 [patent_doc_number] => 08865671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 13/172964 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11885 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587426 [patent_doc_number] => 20110281936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METHODS OF TREATING COGNITIVE DISORDERS BY INHIBITION OF GPR12' [patent_app_type] => utility [patent_app_number] => 13/169739 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15096 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281936.pdf [firstpage_image] =>[orig_patent_app_number] => 13169739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977460 [patent_doc_number] => 20130210890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/805621 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 253 [patent_figures_cnt] => 253 [patent_no_of_words] => 25050 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744668 [patent_doc_number] => 20120022146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'SIGNAL ACTIVATED MOLECULAR DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/167672 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 30819 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022146.pdf [firstpage_image] =>[orig_patent_app_number] => 13167672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669069 [patent_doc_number] => 20110318338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/116722 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29193 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13116722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227481 [patent_doc_number] => 08633149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Targeting PAX2 for the treatment of breast cancer' [patent_app_type] => utility [patent_app_number] => 13/114811 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 60 [patent_no_of_words] => 29210 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014837 [patent_doc_number] => 20110223162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/114824 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29172 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223162.pdf [firstpage_image] =>[orig_patent_app_number] => 13114824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9889132 [patent_doc_number] => 08975388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Method for generating aptamers with improved off-rates' [patent_app_type] => utility [patent_app_number] => 13/113261 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 29 [patent_no_of_words] => 25727 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13113261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708658 [patent_doc_number] => 20130065947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'TREATMENT OF PAR4 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PAR4' [patent_app_type] => utility [patent_app_number] => 13/697875 [patent_app_country] => US [patent_app_date] => 2011-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27714 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938024 [patent_doc_number] => 20110213136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ANTISENSE MODULATION OF STEAROYL-COA DESATURASE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/102811 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35062 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213136.pdf [firstpage_image] =>[orig_patent_app_number] => 13102811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574009 [patent_doc_number] => 20110269665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY' [patent_app_type] => utility [patent_app_number] => 13/101942 [patent_app_country] => US [patent_app_date] => 2011-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8549 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269665.pdf [firstpage_image] =>[orig_patent_app_number] => 13101942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697122 [patent_doc_number] => 20110229468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/098061 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29156 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229468.pdf [firstpage_image] =>[orig_patent_app_number] => 13098061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940586 [patent_doc_number] => 20130190383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'NUCLEIC ACID COMPOUNDS WITH CONFORMATIONALLY RESTRICTED MONOMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/643180 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33302 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000421 [patent_doc_number] => 09044494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21' [patent_app_type] => utility [patent_app_number] => 13/638967 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 26054 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458218 [patent_doc_number] => 08293886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Sensizitation of cancer cells to therapy using sina targeting genes from the 1P and 19Q chromosomal regions' [patent_app_type] => utility [patent_app_number] => 13/053394 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8112 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13053394 [rel_patent_id] =>[rel_patent_doc_number] =>)